Investors
10 investorsAll
Early stage
Mid stage
Late stage
Early stage· 4
Krish W. Ramadurai
Partner at AIX Ventures | Author
early stage
51 investments
Dec 2020
Kent Madsen
Co-Founder and Managing Partner at Epic Venture Funds
early stage
47 investments
Nov 2020
Austin Walters
Healthcare VC @ SpringTide Ventures
early stage
13 investments
May 2019
Tony Horsley
Co-Founder & Managing Director at Rock Creek Capital, LLC
early stage
15 investments
Apr 2019
Mid stage· 5
Jeffrey Bazar
Founder, Managing Director @ JBV Capital
Board Observer (Acquired by Sonic Healthcare)
mid stage
3 investments
Apr 2023
Nyha Shree
Stealth | Early Stage Frontier Tech Investments | Forbes 30Under30 | Singapore top 100 women in tech
Investor ( Exited)
mid stage
3 investments
Jan 2023
Thomas F.
Asset Management
mid stage
19 investments
May 2022
Hem Suri
VC 2.2 | Founder 2.2
Board Observer
mid stage
35 investments
Oct 2021
Anil Sethi
Former Director Apple Health (87M users). CEO Gliimpse (acquired by Apple). CEO Ciitizen (acquired by Invitae). CEO Sequoia (IPO, acquired by Citrix). CTO Dakota (acquired by WebMD).
mid stage
5 investments
2021
Investor geography2 countries
Investor activity2019–2023 · investors recorded per year
Recent (last 2y)Earlier
Frequently asked questions
Who invested in PathologyWatch?
PathologyWatch has 10 investors on record on gritt.io, including 5 early-stage backers, 5 mid-stage.
When did PathologyWatch last raise funding?
The most recent investment in PathologyWatch recorded on gritt.io was in April 2023.
When was PathologyWatch founded?
PathologyWatch was founded in 2018.
What industry is PathologyWatch in?
PathologyWatch operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is PathologyWatch based?
PathologyWatch is headquartered in Salt Lake City, United States.